
Pfizer has recalled two lots of its migraine drug Relpax over concerns about microbiological contamination. In a statement on the …

Pfizer has launched a new website called ‘Campaign Against Migraine’ to help migraine sufferers in the US learn more about …
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

